Medicare Enrolled

Dr. Moonasar Rampertaap, MD

Optician · Bradenton, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
203 3RD AVE E, Bradenton, FL 34208
9417418633
In practice since 2006 (19 years)
NPI: 1558439083 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rampertaap from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rampertaap? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rampertaap

Dr. Moonasar Rampertaap is an optician specialist in Bradenton, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rampertaap performed 2,347 Medicare services across 1,439 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rampertaap received a total of $205,694 from 36 pharmaceutical and/or device companies across 868 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rampertaap is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 34% volume in FL $205,694 industry payments

Florida License Status

FL DOH · MQA
1
Active license
Yes
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 53985 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
2,347
Medicare services
Top 34% in FL for optician
1,439
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~124 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 790 $94 $243
Office visit, established patient, complex (40-54 min) 392 $135 $250
Therapy procedure using a positive pressure ventilator 303 $47 $162
Test for exercise-induced lung stress 151 $26 $125
Test to measure expiratory airflow and volume changes before and after medication administration 149 $29 $94
Test to determine lung volumes using sensors 147 $41 $125
Test to examine how well the lungs exchange gases 147 $42 $175
New patient office visit (45-59 min) 84 $115 $375
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 66 $0 $12
Sleep study in sleep lab (6 years or older) 42 $466 $1,500
Sleep study in sleep lab with continuous airway pressure (6 years or older) 42 $478 $1,625
New patient office visit, complex (60-74 min) 20 $144 $294
Sleep study including heart rate, breathing, airflow, and effort 14 $72 $480
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$205,694
Total received (2018-2024)
Avg $29,385/year across 7 years
Top 2% in FL for optician
36
Companies
868
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$195,977 (95.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,717 (4.2%)
Scientific / Research
Research funding and grants
$1,000 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,441
2023
$1,674
2022
$3,602
2021
$19,628
2020
$20,187
2019
$61,331
2018
$97,832

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
United Therapeutics Corporation
$77,985
Boehringer Ingelheim Pharmaceuticals, Inc.
$77,725
Actelion Pharmaceuticals US, Inc.
$40,908
GlaxoSmithKline, LLC.
$1,936
Takeda Pharmaceuticals U.S.A., Inc.
$1,445
Genentech, Inc.
$1,000
AstraZeneca Pharmaceuticals LP
$890
Grifols USA, LLC
$591
Genentech USA, Inc.
$505
CSL Behring
$430
Mylan Specialty L.P.
$302
Regeneron Healthcare Solutions, Inc.
$244
Amgen Inc.
$183
Insmed, Inc.
$176
Paratek Pharmaceuticals, Inc.
$171
Gilead Sciences, Inc.
$142
Bayer HealthCare Pharmaceuticals Inc.
$139
Vanda Pharmaceuticals Inc.
$113
HARMONY BIOSCIENCES LLC
$93
JAZZ PHARMACEUTICALS INC.
$89
Jazz Pharmaceuticals Inc.
$75
ARALEZ PHARMACEUTICALS US INC.
$72
Harmony Biosciences LLC
$68
GENZYME CORPORATION
$66
Bayer Healthcare Pharmaceuticals Inc.
$64
Philips Electronics North America Corporation
$61
Merck Sharp & Dohme Corporation
$36
Merck Sharp & Dohme LLC
$36
Vapotherm Inc
$23
Ethicon Inc.
$23
Inspire Medical Systems, Inc.
$20
Baxter Healthcare
$19
Nabriva Therapeutics, plc
$17
Sunovion Pharmaceuticals Inc.
$17
Shire North American Group Inc
$15
Resmed Corp
$14
Top 3 companies account for 95.6% of total payments
Associated products mentioned in payments ›
(8874) inCourage · AIRCURVE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CUVITRU · DIFICID · DUPIXENT · Esbriet · FASENRA · GLASSIA · HETLIOZ · Hillrom - Monarch Airway Clearance System · INSPIRE · Monarch Platform · NONE · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Perforomist · Prolastin-C Liquid · REMODULIN · Repatha · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Wakix · XYREM · Xenleta · Xolair · YUPELRI · Yupelri · ZONTIVITY · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for optician in FL.

Equivalent to $8,764 per 100 Medicare services performed
Looking for an optician specialist in Bradenton?
Compare opticians in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
191
Per 100K population
45.9
County median income
$75,792
Nearest hospital
MANATEE MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rampertaap is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 2% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rampertaap experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rampertaap performed 790 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rampertaap receive payments from pharmaceutical companies?
Yes. Dr. Rampertaap received a total of $205,694 from 36 companies across 868 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rampertaap's costs compare to other opticians in Bradenton?
Dr. Rampertaap's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rampertaap) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →